Infosys Q1 Miss and Guidance Cut: AI Deals Hold Stock
Infosys missed Q1 fiscal 2027 earnings estimates and trimmed full-year guidance, yet shares gained 3.7% as investors bet on AI deal momentum and solid margins. The grounded caution: $119.39 million in
Infosys Q1 Miss and Guidance Cut: AI Deals Hold Stock
NEW YORK, July 28 —
Infosys posted a Q1 earnings miss and trimmed its full-year revenue guidance, two developments that in most quarters would push shares lower. Instead, the stock gained 3.7%, lifted by an AI deal pipeline that investors appear to be pricing ahead of the near-term guide-down. The complicating backdrop: executives, led by CEO Salil Parekh, sold $119.39 million in shares in the weeks and months before the quarter reported, with no insider purchases offsetting the flow.
- Shares gained 3.7% despite the guidance cut, as solid Q1 margins and AI deal wins appeared to outweigh the near-term revenue trim, per reporting
- Net insider selling reached $119.39 million over 90 days versus zero in purchases; Parekh's $112.84 million sale accounted for roughly 94% of total insider supply, per Form 4 filings
The Guide-Down in Context
Infosys reported revenue growth year-over-year in Q1 fiscal 2027, but the headline print missed analyst estimates. The company then reduced its full-year revenue guidance, characterized by at least one source as a "guidance cut." By the standard metrics, that combination is a setup for a rough trading session.
Q1 margins held solid, and the AI deal pipeline gave investors a reason to look past the near-term numbers. Sector rebalancing reportedly added to the upward move, per reporting. The market is pricing a deal backlog that has not yet shown up in reported revenue.
The AI Deal Premium
The bull case rests on AI deal wins, which multiple sources cited as the primary factor offsetting the cautious full-year view. Infosys reported trailing twelve-month revenue of $20.30 billion on 2.9% growth, a pace that does not, on its own, justify a 14.4x forward P/E for a mature services business. A gross margin of 29.7% and free cash flow of $3.17 billion confirm operational quality, but the multiple implies AI-driven acceleration that 2.9% growth does not yet support. The deal wins are the bridge. If they convert, the multiple re-rates. If they slip, the valuation looks ahead of itself.
The Selling Pattern
The more pointed question sits in the Form 4 filings. Over the past 90 days, insiders recorded $119.39 million in open-market sales and precisely zero in purchases. Parekh, the CEO and Managing Director, sold 95,800 shares at $1,177.86 per share on May 8, 2026, for approximately $112.84 million, per filings. The CFO, Chief Human Resources Officer, and Chief Legal Officer each completed smaller sales around the same date. None bought.
Insider sales at that scale can reflect compensation structures, estate planning, or routine diversification. The directional uniformity is harder to explain away: every transaction in the 90-day window is a sale, and the aggregate is not incidental. Holding that fact alongside the guidance trim and the earnings miss is reasonable due diligence, not pattern-matching in bad faith.
What the Price Already Assumes
The $49.63 billion market capitalization reflects an AI services story that has not yet fully printed in revenue. Any further guidance reduction without a corresponding surge in deal conversions would compress a spread between price and consensus that is already thin. A company trading above consensus, off an earnings miss, with a trimmed guide, starts the next quarter with less room than the chart implies.
The Next Test
The next hard data point is Q2 fiscal 2027 results. The AI deal wins need to begin converting to reported revenue at a rate that supports or exceeds the lowered full-year guide. Margin sustainability matters too: the 29.7% gross margin and $3.17 billion in free cash flow are genuine strengths, and holding them through an AI-led mix shift is the operational test. The insider posture, a cohort collectively out and not buying, suggests current pricing looks at minimum fair in management's view.
The case for Infosys is real: operational quality, a credible AI services narrative, and a deal pipeline investors are willing to pay for. The case for caution is equally concrete: a Q1 miss, a trimmed guide, $119 million in net insider selling, and a stock trading above what analysts think it is worth. That balance does not argue for a strong view in either direction. It argues for watching Q2 closely.
Run the free Infosys Limited deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Did Infosys beat or miss Q1 2027 estimates?
Infosys missed analyst earnings estimates in Q1 fiscal 2027, though revenue increased year-over-year. The company also trimmed its full-year revenue guidance following the quarter, which at least one source characterized as a guidance cut.
Why did Infosys stock rise after the earnings miss?
Shares gained 3.7% despite the guidance cut, with solid Q1 margins and a pipeline of AI deal wins cited as the primary factors appearing to outweigh the near-term revenue shortfall. Sector rebalancing was also noted as a contributing factor to the post-earnings move.
Is the Infosys CEO selling stock?
CEO Salil Parekh sold 95,800 shares at $1,177.86 per share on May 8, 2026, for approximately $112.84 million, per SEC Form 4 filings. Net insider activity across the executive group over the past 90 days totaled $119.39 million in sales with zero purchases.
What is Infosys' forward P/E and analyst price target?
Infosys trades at a forward P/E of 14.4x, with trailing twelve-month revenue of $20.30 billion and 2.9% revenue growth. The ADR is priced at $12.255, which sits marginally above the analyst consensus price target of $11.85.
What AI deals is Infosys winning?
Multiple sources cited AI deal wins as the primary factor holding Infosys stock up after the guidance cut, with investors appearing to price future deal conversions ahead of current results. The 2.9% trailing revenue growth rate does not yet reflect the AI-driven acceleration the 14.4x forward multiple implies.
Infosys posted a Q1 earnings miss and trimmed its full-year guidance, yet shares have held onto meaningful gains as investors weigh a pipeline of AI deal wins against a more cautious revenue outlook. The resilience in the stock price comes even as executives — including the CEO — sold over $119 million in shares in the months preceding the report.